Giving to Others: How to Change the Face of Medicine

First of all, how are you and your family doing in these COVID-19 times? 

Zee Schwab: Thanks for asking, we’re all thankful, happy and healthy.

Tell us about you, your career, how you founded Sayar.

Zee Schwab: Before we got together with my cofounders Eli Weiss and Moe Norowitz to found Sayar Care, I was studying biochemistry and biology with the idea to enter the medical field. At a point in the process, I interned under the department head of a pediatric oncology/hematology ward at a well-known international hospital. When I was completing my internship, the doctor I interned under sat me down to give me some insight into medicine and what I was thinking to head into.

A small summary of what he told me was that a doctor’s position limits the direct accomplishment I would give to the medical field. He explained that doctors are often stuck with using standard treatments that have not been updated in decades; standards of treatment with high levels of side effects, which are kept in place simply because they were found to work decently, and therefore the research in such fields had lost any level of creativity.

How does Sayar innovate? 

Zee Schwab: At its core, Sayar innovates by realizing the fact that humanity has the interconnectivity of the internet means. Everyone is able to access incredibly large amounts of data means that society can access anything we have already researched, and combine this with newer findings to develop creative treatment ideas at the lowest cost possible. This, in turn, means that people can access better treatments at a lower cost, within a shorter period, and with each person gaining a level of understanding into what they need.

How the coronavirus pandemic affects your business, and how are you coping?

Zee Schwab: We use Amazon for a lot of our sales. Due to corona, Amazon removed the buy button (an easy click-thru used by Amazon) from many sellers. We did see a significant reduction in our business during the peak of the pandemic, which in turn reduced the amount of research we were doing. However, things are now swinging back the other way, so we are beginning to enter the post corona phase. 

Did you have to make difficult choices, and what are the lessons learned?

Zee Schwab: Every choice made has certain difficulty to it. The main thing we’ve learned through difficult decisions is how important it is to make the decision, and to make it quickly—we learned how to not fret over decision making.

How do you deal with stress and anxiety? How do you project yourself and Sayar in the future?

Zee Schwab: I take a look at the problem or the thing causing the stress/anxiety, and then face it directly. This means it cannot tear me apart, and instead, stress/anxiety become problem-solving tools.

Who are your competitors? And how do you plan to stay in the game?

Zee Schwab: Our primary competitors are digital health clinics and various nutraceuticals from Alibaba white label companies. Regardless of these, we are unique in our approach, voice, and the products we develop. This puts us in a place where we don’t have the traditional definition of competitors. We don’t compete. We keep to what we are and who are.

Your final thoughts?

Zee Schwab: This world is a place where humans alone get to innovate and create. To give something new and useful to others is a meaning of life, and this is a principle on which Sayar is founded.

Your website?

sayarcare.com

Our products are also available on amazon.com with free 2-day shipping for prime members